EVOGENE ($EVGN) posted quarterly earnings results for Q4 2025 on Thursday, March 5th. The company reported earnings of -$0.61 per share, missing estimates of -$0.27 by $0.34. The company also reported revenue of $310,000, beating estimates of $280,500 by $29,500.
You can see Quiver Quantitative's $EVGN stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
EVOGENE Hedge Fund Activity
We have seen 4 institutional investors add shares of EVOGENE stock to their portfolio, and 11 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- VIRTU FINANCIAL LLC removed 32,017 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $36,563
- CITADEL ADVISORS LLC added 31,189 shares (+54.2%) to their portfolio in Q4 2025, for an estimated $34,307
- XTX TOPCO LTD added 22,684 shares (+inf%) to their portfolio in Q4 2025, for an estimated $24,952
- MORGAN STANLEY removed 21,292 shares (-70.2%) from their portfolio in Q4 2025, for an estimated $23,421
- TWO SIGMA SECURITIES, LLC removed 11,406 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $12,546
- JANE STREET GROUP, LLC removed 1,481 shares (-3.8%) from their portfolio in Q4 2025, for an estimated $1,629
- BNP PARIBAS FINANCIAL MARKETS removed 1,107 shares (-9.9%) from their portfolio in Q4 2025, for an estimated $1,217
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
